EHCS Intrinsic Valuation and Fundamental Analysis - European Healthcare Acquisition & Growth Company BV - Alpha Spread
E

European Healthcare Acquisition & Growth Company BV
AEX:EHCS

Watchlist Manager
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
Watchlist
Price: 9.9 EUR 1.02%
Market Cap: 83m EUR
Have any thoughts about
European Healthcare Acquisition & Growth Company BV?
Write Note

Intrinsic Value

EHCS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one EHCS stock under the Base Case scenario is 2.95 EUR. Compared to the current market price of 9.9 EUR, European Healthcare Acquisition & Growth Company BV is Overvalued by 70%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EHCS Intrinsic Value
2.95 EUR
Overvaluation 70%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation Backtest
European Healthcare Acquisition & Growth Company BV

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EHCS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EHCS?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about European Healthcare Acquisition & Growth Company BV

Provide an overview of the primary business activities
of European Healthcare Acquisition & Growth Company BV.

What unique competitive advantages
does European Healthcare Acquisition & Growth Company BV hold over its rivals?

What risks and challenges
does European Healthcare Acquisition & Growth Company BV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for European Healthcare Acquisition & Growth Company BV.

Provide P/S
for European Healthcare Acquisition & Growth Company BV.

Provide P/E
for European Healthcare Acquisition & Growth Company BV.

Provide P/OCF
for European Healthcare Acquisition & Growth Company BV.

Provide P/FCFE
for European Healthcare Acquisition & Growth Company BV.

Provide P/B
for European Healthcare Acquisition & Growth Company BV.

Provide EV/S
for European Healthcare Acquisition & Growth Company BV.

Provide EV/GP
for European Healthcare Acquisition & Growth Company BV.

Provide EV/EBITDA
for European Healthcare Acquisition & Growth Company BV.

Provide EV/EBIT
for European Healthcare Acquisition & Growth Company BV.

Provide EV/OCF
for European Healthcare Acquisition & Growth Company BV.

Provide EV/FCFF
for European Healthcare Acquisition & Growth Company BV.

Provide EV/IC
for European Healthcare Acquisition & Growth Company BV.

Compare the intrinsic valuations
of European Healthcare Acquisition & Growth Company BV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of European Healthcare Acquisition & Growth Company BV against its competitors.

Analyze the profit margins
(gross, operating, and net) of European Healthcare Acquisition & Growth Company BV compared to its peers.

Compare the P/E ratios
of European Healthcare Acquisition & Growth Company BV against its peers.

Discuss the investment returns and shareholder value creation
comparing European Healthcare Acquisition & Growth Company BV with its peers.

Analyze the financial leverage
of European Healthcare Acquisition & Growth Company BV compared to its main competitors.

Show all profitability ratios
for European Healthcare Acquisition & Growth Company BV.

Provide ROE
for European Healthcare Acquisition & Growth Company BV.

Provide ROA
for European Healthcare Acquisition & Growth Company BV.

Provide ROIC
for European Healthcare Acquisition & Growth Company BV.

Provide ROCE
for European Healthcare Acquisition & Growth Company BV.

Provide Gross Margin
for European Healthcare Acquisition & Growth Company BV.

Provide Operating Margin
for European Healthcare Acquisition & Growth Company BV.

Provide Net Margin
for European Healthcare Acquisition & Growth Company BV.

Provide FCF Margin
for European Healthcare Acquisition & Growth Company BV.

Show all solvency ratios
for European Healthcare Acquisition & Growth Company BV.

Provide D/E Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide D/A Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Interest Coverage Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Altman Z-Score Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Quick Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Current Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Cash Ratio
for European Healthcare Acquisition & Growth Company BV.

What is the historical Revenue growth
over the last 5 years for European Healthcare Acquisition & Growth Company BV?

What is the historical Net Income growth
over the last 5 years for European Healthcare Acquisition & Growth Company BV?

What is the current Free Cash Flow
of European Healthcare Acquisition & Growth Company BV?

Discuss the annual earnings per share (EPS)
trend over the past five years for European Healthcare Acquisition & Growth Company BV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
European Healthcare Acquisition & Growth Company BV

Balance Sheet Decomposition
European Healthcare Acquisition & Growth Company BV

Current Assets 15.9m
Cash & Short-Term Investments 13.9m
Receivables 1.8m
Other Current Assets 169k
Current Liabilities 14m
Accounts Payable 1.3m
Other Current Liabilities 12.7m
Efficiency

Earnings Waterfall
European Healthcare Acquisition & Growth Company BV

Revenue
0 EUR
Cost of Revenue
6m EUR
Gross Profit
6m EUR
Operating Expenses
-3m EUR
Operating Income
3m EUR
Other Expenses
23.5m EUR
Net Income
26.5m EUR

Free Cash Flow Analysis
European Healthcare Acquisition & Growth Company BV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EHCS Profitability Score
Profitability Due Diligence

European Healthcare Acquisition & Growth Company BV's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Positive Operating Income
Positive Net Income
Positive Gross Profit
25/100
Profitability
Score

European Healthcare Acquisition & Growth Company BV's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

EHCS Solvency Score
Solvency Due Diligence

European Healthcare Acquisition & Growth Company BV's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
57/100
Solvency
Score

European Healthcare Acquisition & Growth Company BV's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EHCS Price Targets Summary
European Healthcare Acquisition & Growth Company BV

There are no price targets for EHCS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EHCS?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for EHCS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about EHCS dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

EHCS Price
European Healthcare Acquisition & Growth Company BV

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-1%
5Y 5Y
-1%
10Y 10Y
-1%
Annual Price Range
9.9
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -7%
Shares Statistics
Market Capitalization 78.3m EUR
Shares Outstanding 8 384 757
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

European Healthcare Acquisition & Growth Company BV

Country

Germany

Industry

N/A

Market Cap

78.3m EUR

Dividend Yield

0%

Description

European Healthcare Acquisition & Growth Company BV is an operators-led special purpose acquisition company. The company is headquartered in Munich, Bayern. The company went IPO on 2021-11-18. The Firm’s business purpose is to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm focuses its search for a potential target business in Europe, in such as Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics, as well as Life Science Tools.

Contact

BAYERN
Munich
Theresienhohe 28
www.ehc-company.com

IPO

2021-11-18

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one EHCS stock?

The intrinsic value of one EHCS stock under the Base Case scenario is 2.95 EUR.

Is EHCS stock undervalued or overvalued?

Compared to the current market price of 9.9 EUR, European Healthcare Acquisition & Growth Company BV is Overvalued by 70%.

Back to Top